News
Scientists discover verbal fluency outperforms memory and vocabulary tests as a predictor of longer life in older adults. Religious leaders arrested in $50M human trafficking, forced labor scheme Emma ...
SpaceX’s Starship rocket launched to space and deployed satellites for the first time before surviving most of its journey to Earth, achieving new technological milestones after a year of fiery ...
Aehr received an evaluation order from a major AI processor supplier for wafer-level burn-in technology. Shares surged over 8% premarket after the announcement, extending momentum from a separate ...
US stock market futures moved higher on Thursday as the Dow Jones, S&P 500, and Nasdaq all traded in green before the release ...
Hosted on MSN
Nvidia Earnings Loom As Key Test For AI Rally
Nvidia earnings this week will be a key market catalyst after Federal Reserve Chair Jerome Powell signaled rate cuts are coming, easing investor concerns, according to Bloomberg. The S&P 500 logged ...
S&P 500 Likely to Test Key Support Following Yesterday’s Late-Day Selling By Michael Kramer Market Overview Published 08/26/2025, 12:26 AM ...
RIO DE JANEIRO, Aug 27 (Reuters) - Brazilian state-run oil firm Petrobras on Wednesday concluded an emergency drill in the country's Foz do Amazonas basin, the company and Brazil's environmental ...
When the Tampa Bay Buccaneers selected wide receiver Emeka Egbuka with pick No. 19 in the 2025 NFL Draft, the choice seemed surprising. The Buccaneers already have a talented receiving corps, which ...
Breaking stock news is now free. Create your account to stay informed—and explore the insights behind every move. Bicycle Therapeutics plc ( NASDAQ: BCYC) Morgan Stanley 23rd Annual Global Healthcare ...
Bitcoin bears hold strong incentives below $114,000, likely intensifying pressure ahead of the options expiry. AI-sector spending concerns add turbulence and weigh on investors’ broader risk appetite.
Shares of Eli Lilly (LLY) closed nearly 6% higher on Tuesday after the company announced its obesity pill, orforglipron, "met the primary and all key secondary endpoints" in its phase 3 trial. Yahoo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results